Wednesday, January 22, 2020 4:13:19 PM
Exhibit 99.1
TO: Todd S. Caven
Chief Financial Officer and
Director / Board Member
Regen BioPharma, Inc.
Zander Therapeutics, Inc.
KCL Therapeutics, Inc.
RE: Resignation as officer and director of Regen BioPharma Inc., Zander Therapeutics Inc. and KCL Therapeutics Inc.
Effective as of 1 pm Pacific Standard Time on January 22, 2020 I resign my positions as Chairman of the Board of Directors, Chief Executive Officer and any and all other offices I may hold of Regen BioPharma Inc., Zander Therapeutics Inc. and KCL Therapeutics Inc.
This leaves you serving as the sole officer and director of the abovementioned three corporations.
I am available to serve as a consultant should you desire. Terms of such service shall be negotiated separately on a case by case basis.
Sincerely,
/s/ David R. Koos
David R. Koos
1/22/2020
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM